ID 61204
FullText URL
74_6_461.pdf 1.93 MB
Kono, Yoshiyasu Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kanzaki, Hiromitsu Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID publons researchmap
Iwamuro, Masaya Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Kawano, Seiji Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID
Kawahara, Yoshiro Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Okada, Hiroyuki Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Gastric cancer usually arises in middle-aged to older patients, and is rarely found in younger patients. The clin-ical characteristics, etiology, prognosis, preventive methods and treatment of gastric cancer in young patients have not been fully investigated because of its low prevalence. In this review, we discuss the current under-standing and clinical problems associated with gastric cancer in young patients. Helicobacter pylori (H. pylori), which is a major cause of gastric cancer, especially in older populations, is closely associated with gastric cancer in young patients as well as in older patients. Gastric cancer in young patients tends to be diagnosed at an advanced stage with alarm symptoms. However, young patients with advanced gastric cancer tend to have a favorable general condition and organ function, so they can tolerate intensive systematic chemotherapy. Unfortunately, the prognosis of gastric cancer in young patients with an advanced stage is not favorable. We should not take this rare disease lightly, given its poor prognosis if patients are diagnosed at an unresectable stage. The evaluation of the H. pylori infection status and performance of H. pylori eradication therapy to prevent gastric cancer in young patients as well as the development of more intensive chemotherapy regimens for unre-sectable gastric cancer in young patients are warranted.
gastric cancer
young patients
Helicobacter pylori
Amo Type
Published Date
Publication Title
Acta Medica Okayama
Okayama University Medical School
Start Page
End Page
Content Type
Journal Article
Copyright Holders
CopyrightⒸ 2020 by Okayama University Medical School
File Version
PubMed ID
Web of Science KeyUT
Uemura N, Okamoto S, Yamamoto S, Matsuura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RI: Helico-bacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 345: 784-789.
Brenner H, Rothenbacher D and Arndt V: Epidemiology of stom-ach cancer. Methods Mol Biol (2009) 472: 467-477.
Umeyama K, Sowa M, Kamino K, Kato Y and Satake K: Gastric carcinoma in young adults in Japan. Anticancer Res (1982) 2: 283-286.
Ramos-De la Medina A, Salgado-Nesme N, Torres-Vilalobos G and Medina-Franco H: Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg (2004) 8: 240-244.
Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J and Szczepanik AM: Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg (2008) 393: 37-43.
Chung HW, Noh SH and Lim JB: Analysis of demographic char-acteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol (2010) 16: 256-263.
Smith AW, Bellizzi KM, Keegan TH, Zebrack B, Chen VW, Neale AV, Hakilton AS, Shnorhavorian M and Lynch CF: Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol (2013) 31: 2136-2145.
De B, Rhome R, Jairam V, Ozbek U, Holcombe RF, Buckstein M and Ang C: Gastric adenocarcinoma in young adult patients: pat-terns of care and survival in the United States. Gastric Cancer (2018) 21: 889-899.
Li J: Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis. Gastroenterol Res Pract (2020) 2020: 9512707.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2018) 68: 394-424.
Merchant SJ, Kim J, Choi AH, Sun V, Chao J and Nelson R: A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer (2017) 20: 226-234.
Kokkola A and Sipponen P: Gastric carcinoma in young adults. Hepatogastroenterology (2001) 48: 1552-1555.
Isobe T, Hashimoto K, Kizaki J, Miyagi M, Aoyagi K, Koufuji K and Shirouzu K: Characteristics and prognosis of gastric cancer in young patients. Oncol Rep (2013) 30: 43-49.
Liu S, Feng F, Xu G, Liu Z, Tian Y, Guo M, Lian X, Cai L, Fan D and Zhang H: Clinicopathological features and prognosis of gastric cancer in young patients. BMC Cancer (2016) 16: 478.
Takatsu Y, Hiki N, Nunobe S, Ohashi M, Honda M, Yamaguchi T, Nakajima T and Sano T: Clinicopathological features of gastric cancer in young patients. Gastric Cancer (2016) 19: 472-478.
Maeta M, Yamashiro H, Oka A, Tsujitani S, Ikeguchi M and Kaibara N: Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol (1995) 58: 191-195.
Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D and McColl KE: Oesophageal and gastric intestinal-type adenocarcino-mas show the same male predominance due to a 17 year delayed development in females. Gut (2009) 58: 16-23.
Nakamura R, Saikawa Y, Takahashi T, Takeuchi H, Asanuma H, Yamada Y and Kitagawa Y: Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol (2011) 16: 328-334.
Hsieh FJ, Wang YC, Hsu JT, Liu KH and Yeh CN: Clinicopath-ological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol (2012) 105: 304-309.
Wang Z, Xu J, Shi Z, Shen X, Luo T, Bi J and Nie M: Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol (2016) 51: 1043-1049.
Zhou F, Shi J, Fang C, Zou X and Huang Q: Gastric Carcinomas in Young (Younger than 40 Years) Chinese Patients: Clinicopath-ology, Family History, and Postresection Survival. Medicine (Baltimore) (2016) 95:e2873.
Ji T, Zhou F, Wang J and Zi L: Risk factors for lymph node metastasis of early gastric cancers in patients younger than 40. Medicine (Baltimore) (2017) 96: e7874.
Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H and Tang P: Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Hum Pathol (2008) 39: 1809-1815.
Correa P, Haenszel W, Cuello C, Tannenbaum S and Archer M: A model for gastric cancer epidemiology. Lancet (1975) 2: 58-60.
Correa P: Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol (1995) 19 Suppl 1: S37-43.
Herrera V and Parsonnet J: Helicobacter pylori and gastric adeno-carcinoma. Clin Microbiol Infect (2009) 15: 971-976.
Cokkinides VE, Bandi P, Siegel RL and Jemal A: Cancer-related risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin (2012) 62: 353-363.
Correa P and Shiao YH: Phenotypic and genotypic events in gas-tric carcinogenesis. Cancer Res (1994) 54(7 Suppl): 1941s-1943s.
Milne AN, Sitarz R, Carvalho R, Carneiro F and Offerhaus GJ: Early onset gastric cancer: on the road to unraveling gastric car-cinogenesis. Curr Mol Med (2007) 7: 15-28.
Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, Mohammadkhani A, Attari A, Akbari MR, Hormazdi M and Malekzadeh R: Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol (2004) 4: 28.
Derks S, Liao X, Chiaravalli AM, Xu X, Camargo MC, Solcia E, Sessa F, Fleitas T, Freeman GJ, Rodig SJ, Rabkin CS and Bass AJ: Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers. Oncotarget (2016) 7: 32925-32932.
Cancer Genome Atlas Research Network. Nature (2014) 513: 202-209.
Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, Jin JG, Choi MG, Sohn TS, Lee JH, Bae JM, Kim ST, Park SH, Sohn I, Jung SH, Tan P, Chen R, Hardwich J, Kang WK, Ayers M, Hongyue D, Reinhard C, Loboda A, Kim S and Aggarwal A: Molecular analysis of gastric cancer identifies sub-types associated with distinct clinical outcomes. Nat Med (2015) 21: p. 449-456.
Murphy G, Pfeiffer R, Camargo MC and Rabkin CS: Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 137: 824-833.
Shibata D and Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 140: 769-774.
Shibata D, Hawes D, Stemmermann GN and Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev (1993) 2: 213-217.
Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, Fabiano A, Sidoni A and Covacci A: Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer (1999) 85: 2506-2511.
Moore A, Hikri E, Goshen-Lago T, Barkan T, Morgenstern S, Brook E, Maderer A, Roth W, Gordon N, Kashtan H, Brenner B, Moehler M and Aharon IB: Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?BMC Cancer (2020) 20: 34.
Matley PJ, Dent DM, Madden MV and Price SK: Gastric carci-noma in young adults. Ann Surg (1988) 208: 593-596.
Kokkola A, Valle J, Haapiainen R, Sipponen P, Kivilaakso E and Puolakkainen P: Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol (1996) 31: 643-647.
Nam JH, Choi IJ, Cho SJ, Kim CG, Lee JY, Nam SY, Park SR, Kook MC, Nam BH and Kim YW: Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients. J Gastroenterol Hepatol (2011) 26: 1157-1163.
Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Wen X, Lopes C, Figueiredo C, Marchado JC, Ferreira RM, Reis CA, Canedo P, Duraes C, Ferreira J, Pedroto I and Areias J: First-degree rela-tives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch (2013) 463: 391-399.
Bautista MC, Jiang SF, Armstrong MA, Postlethwaite D and Li D: Impact of age on clinicopathological features and survival of patients with noncardia gastric adenocarcinoma. J Gastric Cancer (2014) 14: 238-245.
Pisanu A, Podda M, Cois A and Uccheddu A: Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study. Gastroenterol Res Pract (2014) 2014: 125038.
Lee J, Lee MA, Kim IH and Roh SY: Clinical characteristics of young-age onset gastric cancer in Korea. BMC Gastroenterol (2016) 16: 110.
Kono Y, Kanzaki H, Tsuzuki T, Takatani M, Nasu J, Kawai D, Takenaka R, Tanaka T, Iwamuro M, Kawano S, Kawahara Y, Fujiwata T and Okada H: A multicenter observational study on the clinicopathological features of gastric cancer in young patients. J Gastroenterol (2019) 54: 419-426.
Shiota S, Murakawi K, Suzuki R, Fujioka T and Yamaoka Y: Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol (2013) 7: 35-40.
Haruma K, Komoto K, Kamada T, Ito M, Kitadai Y, Yoshihara M, Sumii K and Kajiyama G: Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol (2000) 35: 255-259.
Koshida Y, Koizumi W, Sasabe M, Katoh Y and Okayasu I: Association of Helicobacter pylori-dependent gastritis with gastric carcinomas in young Japanese patients: histopathological compar-ison of diffuse and intestinal type cancer cases. Histopathology (2000) 37: 124-130.
Bani-Hani KE: Clinicopathological comparison between young and old age patients with gastric adenocarcinoma. Int J Gastrointest Cancer (2005) 35: 43-52.
Tavares A, Gandra A, Viveros F, Cidade C and Maciel J: Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients. Pathol Oncol Res (2013) 19: 111-117.
Tatemichi M, Sasazuki S, Inoue M and Tsugane S: Different etio-logical role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface anti-gen. Acta Oncol (2008) 47: 360-365.
Hirahashi M, Yao T, Matsumoto T, Nishiyama K, Oya M, Iida M and Tsuneyoshi M: Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia. Mod Pathol (2007) 20: 29-34.
Miyamoto M, Haruma K, Yoshihara M, Hiyama T, Sumioka M, Nishisaka T, Tanaka S and Chayama K: Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis Sci (2003) 48: 968-975.
Kitamura S, Yasuda M, Muguruma N, Okamoto K, Takeuchi H, Bando Y, Miyamoto H, Okahisa T, Yano M, Torisu R and Takayama T: Prevalence and characteristics of nodular gastritis in Japanese elderly. J Gastroenterol Hepatol (2013) 28: 1154-1160.
Rona KA, Schwameis K, Zehetner J, Samakar K, Green K, Samaan J, Sandhu K, Bildzukewicz N, Katkhouda N and Lipham JC: Gastric cancer in the young: An advanced disease with poor prognostic features. J Surg Oncol (2017) 115: 371-375.
Liu W, Quan H, Chen X, Ouyang Y and Xiao H: Clinicopathological features and prognosis of young gastric cancer patients following radical gastrectomy: a propensity score matching analysis. Sci Rep (2019) 9: 5943.
Tekesin K, Emin Gunes M, Tural D, Akar E, Zirtiloglu A, Karaca M, Selcukbiricik F, Bayrak S and Ozet A: Clinicopathological charac-teristics, prognosis and survival outcome of gastric cancer in young patients: A large cohort retrospective study. J buon (2019) 24: 672-678.
Cormedi MCV, Katayama MLH, Guindalini RSC, Faraj SF and Folgueira Maak: Survival and prognosis of young adults with gas-tric cancer. Clinics (Sao Paulo) (2018) 73(suppl 1): e651s.
Maconi G, Kurihara H, Panizzo V, Russo A, Cristaldi M, Marrelli D, Roviello F, de Manzoni G, Di Leo A, Morgagni P, Bechi P, Bianchi Porro G and Taschieri AM: Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol (2003) 38: 1249-1255.
Ford AC, Forman D, Hunt RH, Yuan Y and Moayyedi P: Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. Bmj (2014) 348: g3174.
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS and Graham DY: Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology (2016) 150: 1113-1124.e5.
Ramos MFKP, Pereira MA, Sagae VMT, Mester M, Morrell ALG, Dias AR, Zilberstein B, Ribeiro Junior U and Cecconello I: Gastric cancer in young adults: a worse prognosis group? Rev Col Bras Cir (2019) 46: e20192256.
Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E and Yamaguchi K: Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer. Cancer Manag Res (2018) 10: 5283-5290.